ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XTLB XTL Biopharmaceuticals Ltd

2.44
0.00 (0.00%)
Apr 19 2024 - Closed
Delayed by 15 minutes

XTL Biopharmaceuticals Financial Summary

The current XTLB market cap is 0. The company's latest EPS is USD and P/E is N/A.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -204k-225k-251k-163k-151k
Net Income -821k-748k-919k-364k-215k
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -793k-842k-948k-1.03M-880k
Net Income 2.99M-1.35M-782k435k-1.35M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 4.9M4.19M3.32M2.88M2.66M
Total Liabilities 153k187k241k163k162k
Total Equity 4.74M4M3.08M2.72M2.5M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 8.58M7.21M6.5M6.62M4.19M
Total Liabilities 253k232k254k1.29M187k
Total Equity 8.32M6.98M6.25M5.33M4M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating N/A -901k N/A N/A N/A
Investing N/A 36k N/A N/A N/A
Financing N/A N/A N/A N/A N/A
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -816k-908k-850k2.87M-901k
Investing 778k2.11M32k8k36k
Financing N/A N/A N/A 385k N/A
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 0
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.83 (28.33%)

Company Info

Company Name XTL Biopharmaceuticals Ltd
Address 5 badner st
ramat gan, center 5218102
Website https://www.xtlbio.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock